Mauro Mansutti

2.3k total citations
43 papers, 1.5k citations indexed

About

Mauro Mansutti is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mauro Mansutti has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 26 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mauro Mansutti's work include Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (21 papers) and HER2/EGFR in Cancer Research (14 papers). Mauro Mansutti is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (21 papers) and HER2/EGFR in Cancer Research (14 papers). Mauro Mansutti collaborates with scholars based in Italy, United States and Spain. Mauro Mansutti's co-authors include Fabio Puglisi, Alessandro Marco Minisini, Gianpiero Fasola, Pinuccia Valagussa, Semiglazov Vf, Milvia Zambetti, Aňa Lluch, Luca Gianni, W. Eiermann and А. А. Божок and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Mauro Mansutti

43 papers receiving 1.5k citations

Peers

Mauro Mansutti

ONCOL

PRM

RNMI

H. Curé France

R. Largillier France

Thomas E. Seay United States

Mary Cianfrocca United States

Daniel Vorobiof South Africa

Anne‐Laure Martin France

Nils‐Olof Bengtsson Sweden

Ted Vandenberg Canada

Pınar Saip Türkiye

Emmanuel Gabriel United States

H. Curé France

Mauro Mansutti

1.2k ×1.1

ONCOL

742 ×1.0

327 ×1.0

PRM

183 ×1.0

118 ×0.6

RNMI

Citations per year, relative to Mauro Mansutti Mauro Mansutti (= 1×) peers H. Curé

Countries citing papers authored by Mauro Mansutti

Since Specialization

Citations

This map shows the geographic impact of Mauro Mansutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Mansutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Mansutti more than expected).

Fields of papers citing papers by Mauro Mansutti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Mansutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Mansutti. The network helps show where Mauro Mansutti may publish in the future.

Co-authorship network of co-authors of Mauro Mansutti

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Mansutti. A scholar is included among the top collaborators of Mauro Mansutti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Mansutti. Mauro Mansutti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Targato, Giada, et al.. (2022). CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature. Current Oncology. 29(12). 9630–9639. 2 indexed citations

Targato, Giada, Elisa Bertoli, Claudia Andreetta, et al.. (2022). Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?. Frontiers in Oncology. 12. 885992–885992. 3 indexed citations

Basile, Debora, Giada Targato, Marco Alberti, et al.. (2021). 295P Clinical characterization and outcome of a HER2-low metastatic breast cancer (mBC) cohort receiving first-line treatment (1L) with ET +/- CDK 4/6 inhibitor (CDKi). Annals of Oncology. 32. S493–S493. 3 indexed citations

Bonotto, Marta, Debora Basile, Lorenzo Gerratana, et al.. (2018). Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. The Breast. 40. 45–52. 6 indexed citations

Bonotto, Marta, Lorenzo Gerratana, Giacomo Pelizzari, et al.. (2018). Association of clinical factors and biological subtypes with different Ca15-3 levels in metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). e24014–e24014. 1 indexed citations

Bonotto, Marta, Lorenzo Gerratana, Massimo Di Maïo, et al.. (2016). Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. The Breast. 31. 114–120. 38 indexed citations

Bonotto, Marta, Lorenzo Gerratana, Grazia Arpino, et al.. (2015). First line treatment in patients with luminal-like metastatic breast cancer: a propensity score-matched analysis. Annals of Oncology. 26. vi8–vi8. 1 indexed citations

Gerratana, Lorenzo, Barbara Toffoletto, Michela Bulfoni, et al.. (2015). Metastatic breast cancer and circulating exosomes. Hints from an exploratory analysis. Annals of Oncology. 26. vi14–vi14. 7 indexed citations

Fontanella, Caterina, et al.. (2015). Novel antiangiogenic drugs for the management of breast cancer: new approaches for an old issue?. Expert Review of Clinical Pharmacology. 8(2). 251–265. 7 indexed citations

10.

Bonotto, Marta, Lorenzo Gerratana, Elena Poletto, et al.. (2014). Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario. The Oncologist. 19(6). 608–615. 220 indexed citations

11.

Gianni, Luca, W. Eiermann, Semiglazov Vf, et al.. (2014). Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. The Lancet Oncology. 15(6). 640–647. 356 indexed citations

12.

Fasola, Gianpiero, et al.. (2014). Drug waste minimization as an effective strategy of cost-containment in Oncology. BMC Health Services Research. 14(1). 57–57. 60 indexed citations

13.

Zambetti, Milvia, Mauro Mansutti, Patricia Gómez, et al.. (2011). Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II). Breast Cancer Research and Treatment. 132(3). 843–851. 42 indexed citations

14.

Mustacchi, Giorgio, Mauro Mansutti, Chiara Sacco, et al.. (2009). Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study. Annals of Oncology. 20(4). 655–659. 15 indexed citations

15.

Fasola, Gianpiero, Marianna Aita, L. D. Marini, et al.. (2008). Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study. BMC Health Services Research. 8(1). 70–70. 56 indexed citations

16.

Puglisi, Fabio, Giovanni Gerardo Cardellino, Diana Crivellari, et al.. (2008). Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer. Annals of Oncology. 19(9). 1541–1546. 37 indexed citations

17.

Minisini, Alessandro Marco, Carla Di Loreto, Mauro Mansutti, et al.. (2004). Topoisomerase IIα and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancer. Cancer Letters. 224(1). 133–139. 21 indexed citations

18.

Minisini, Alessandro Marco, Antonellá Tosti, Alberto Sobrero, et al.. (2003). Taxane-induced nail changes: incidence, clinical presentationand outcome. Annals of Oncology. 14(2). 333–337. 103 indexed citations

19.

Bonadonna, Gianni, Milvia Zambetti, C. Bumma, et al.. (2002). Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group. Annals of Oncology. 13(7). 1049–1058. 7 indexed citations

20.

Veronesi, Andrea, et al.. (1996). Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients. European Journal of Cancer. 32(10). 1809–1811. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact